Alexza Pharmaceuticals Inc (ALXA) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2091 STIERLIN COURT MOUNTAIN VIEW, CA 94043 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7,755 | 11,287 | 15,696 | 22,520 | 34,774 | 34,887 | |||
| Cash and cash equivalent | 7,755 | 11,287 | 12,193 | 11,093 | 15,200 | 11,626 | |||
| Short-term investments | 3,503 | 11,427 | 19,574 | 23,261 | |||||
| Receivables | 822 | 303 | 99 | 173 | 1,008 | ||||
| Inventory, net of allowances, customer advances and progress billings | 103 | 1,407 | 2,472 | 3,729 | 4,414 | ||||
| Inventory | 103 | 1,407 | 2,472 | 3,729 | 4,414 | ||||
| Advances on inventory purchases | 1,024 | 1,024 | 1,024 | 1,024 | |||||
| Other undisclosed current assets | 2,213 | 188 | 541 | 1,145 | 3,109 | 3,039 | |||
| Total current assets: | 10,992 | 13,424 | 18,971 | 27,260 | 41,785 | 43,348 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 3,320 | 10,301 | 11,014 | 11,693 | 13,953 | 15,017 | |||
| Restricted cash and investments | 1,361 | 2,757 | 4,160 | ||||||
| Other noncurrent assets | 419 | 2,497 | 2,648 | 2,856 | 3,065 | 3,272 | |||
| Total noncurrent assets: | 3,739 | 12,798 | 13,662 | 15,910 | 19,775 | 22,449 | |||
| TOTAL ASSETS: | 14,731 | 26,222 | 32,633 | 43,170 | 61,560 | 65,797 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 7,432 | 6,617 | 5,449 | 4,678 | 10,417 | 6,461 | |||
| Employee-related liabilities | 2,781 | ||||||||
| Accounts payable | 442 | 905 | 2,618 | 1,565 | 1,799 | 1,692 | |||
| Accrued liabilities | 6,990 | 5,712 | 2,831 | 3,113 | 5,837 | 4,769 | |||
| Debt | 46,840 | 2,914 | 64,157 | 63,767 | 63,579 | ||||
| Business combination, contingent consideration, liability | 900 | 800 | 900 | 800 | 1,700 | 1,400 | |||
| Deferred revenue and credits | 2,848 | 2,848 | 2,970 | 2,450 | 2,450 | 2,374 | |||
| Other undisclosed current liabilities | 178 | 134 | 689 | (63,844) | (66,817) | (62,821) | |||
| Total current liabilities: | 58,198 | 13,313 | 10,008 | 8,241 | 11,517 | 10,993 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 21,127 | 67,688 | 64,530 | 64,157 | 63,767 | 63,378 | |||
| Long-term debt, excluding current maturities | 21,127 | 64,774 | 64,530 | 64,157 | 63,767 | 63,378 | |||
| Other undisclosed long-term debt and lease obligation | 2,914 | ||||||||
| Liabilities, other than long-term debt | 7,064 | 16,984 | 22,005 | 22,439 | 37,929 | 40,265 | |||
| Deferred revenue and credits | 3,412 | 4,471 | 5,530 | 6,902 | 7,844 | 7,336 | |||
| Other liabilities | 1,752 | 1,613 | 1,475 | 1,237 | 985 | 729 | |||
| Business combination, contingent consideration, liability | 1,900 | 10,900 | 15,000 | 14,300 | 29,100 | 32,200 | |||
| Total noncurrent liabilities: | 28,191 | 84,672 | 86,535 | 86,596 | 101,696 | 103,643 | |||
| Total liabilities: | 86,389 | 97,985 | 96,543 | 94,837 | 113,213 | 114,636 | |||
| Equity | |||||||||
| Equity, attributable to parent | (71,658) | (68,849) | (63,910) | (51,667) | (51,653) | (48,839) | |||
| Common stock | 2 | 2 | 2 | 2 | 2 | 2 | |||
| Additional paid in capital | 360,610 | 360,401 | 359,902 | 359,696 | 359,308 | 355,413 | |||
| Accumulated other comprehensive loss | (1) | (3) | (1) | ||||||
| Accumulated deficit | (432,270) | (429,252) | (423,814) | (411,364) | (410,960) | (404,253) | |||
| Total equity: | (71,658) | (68,849) | (63,910) | (51,667) | (51,653) | (48,839) | |||
| Other undisclosed liabilities and equity | (2,914) | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 14,731 | 26,222 | 32,633 | 43,170 | 61,560 | 65,797 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 673 | 1,773 | 1,875 | 705 | 1,454 | 457 | ||
| Revenue, net | 1,773 | 1,875 | 618 | 536 | 364 | |||
| Cost of revenue (Cost of Product and Service Sold) | (7,175) | (3,675) | (4,132) | (6,147) | (3,952) | (3,279) | ||
| Gross profit: | (6,502) | (1,902) | (2,257) | (5,442) | (2,498) | (2,822) | ||
| Operating expenses | (2,100) | (5,695) | (7,184) | (8,942) | (4,774) | (7,218) | ||
| Other undisclosed operating income (loss) | (1,381) | 1,381 | 8 | |||||
| Operating loss: | (9,983) | (7,597) | (9,441) | (13,003) | (7,264) | (10,040) | ||
| Interest and debt expense | (2,050) | (1,969) | (2,198) | (2,229) | (2,234) | (2,202) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1,032 | |||||||
| Loss from continuing operations: | (12,033) | (9,566) | (11,639) | (15,232) | (8,466) | (12,242) | ||
| Loss before gain (loss) on sale of properties: | (12,033) | (9,566) | (11,639) | (15,232) | (8,466) | (12,242) | ||
| Net loss: | (12,033) | (9,566) | (11,639) | (15,232) | (8,466) | (12,242) | ||
| Other undisclosed net income (loss) attributable to parent | 9,015 | 4,128 | (811) | 14,828 | 1,759 | (1,086) | ||
| Net loss available to common stockholders, diluted: | (3,018) | (5,438) | (12,450) | (404) | (6,707) | (13,328) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (12,033) | (9,566) | (11,639) | (15,232) | (8,466) | (12,242) | ||
| Other comprehensive loss | (12,449) | (402) | (6,709) | (13,331) | ||||
| Comprehensive loss: | (12,033) | (9,566) | (24,088) | (15,634) | (15,175) | (25,573) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 9,018 | 4,125 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (3,015) | (5,441) | (24,088) | (15,634) | (15,175) | (25,573) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.